A multicentre, randomised, double blind, placebo-controlled, parallel group trial of the effectiveness of the nocturnal use of a Temperature Controlled Laminar Airflow (TLA) device (Protexo®) in adults with poorly-controlled, severe allergic asthma: the LASER trial

    Project Details

    Description

    Funded by the NIHR Health Technology Assessment programme
    StatusFinished
    Effective start/end date1/12/1331/05/17

    Collaborative partners

    Funding

    • Portsmouth Hospitals University NHS Trust: £15,499.00

    UN Sustainable Development Goals

    In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

    • SDG 3 - Good Health and Well-being

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.